Document Detail


Prostaglandin F2alpha promotes muscle cell survival and growth through upregulation of the inhibitor of apoptosis protein BRUCE.
MedLine Citation:
PMID:  18566603     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
During skeletal muscle growth and regeneration, the majority of differentiating myoblasts undergoes cell-cell fusion to form multinucleated myofibers, whereas a proportion of myoblasts undergoes apoptosis. The treatment of myoblasts with prostaglandin F2alpha (PGF2alpha) during myogenesis in vitro leads to the formation of large myotubes, but the mechanism by which PGF2alpha promotes myotube growth has not been investigated. Here, we demonstrate that PGF2alpha reduces cell death during myogenesis in vitro and in vivo. In addition, we show that PGF2alpha increases expression of the inhibitor of apoptosis protein (IAP) BRUCE through a pathway dependent on the nuclear factor of activated T cell 2 transcription factor. Importantly, PGF2alpha-mediated reduction in muscle cell death is dependent on BRUCE, and overexpression of BRUCE is sufficient to promote muscle cell survival and growth. These results establish a previously unrecognized link between NFAT signaling and regulation of IAP expression and are the first to identify a signaling pathway that increases BRUCE expression. In addition, our results provide evidence that increasing the pool of muscle cells available for fusion by inhibiting cell death enhances myotube growth.
Authors:
K M Jansen; G K Pavlath
Related Documents :
8167933 - Behavior of arterial wall cells cultured on periodically stretched substrates.
18824083 - Supplemental nitric oxide augments satellite cell activity on cultured myofibers from a...
11191113 - Disruption of cell cycle kinetics by benzo[a]pyrene: inverse expression patterns of brc...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2008-06-20
Journal Detail:
Title:  Cell death and differentiation     Volume:  15     ISSN:  1350-9047     ISO Abbreviation:  Cell Death Differ.     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2008-09-16     Completed Date:  2008-10-27     Revised Date:  2010-08-09    
Medline Journal Info:
Nlm Unique ID:  9437445     Medline TA:  Cell Death Differ     Country:  England    
Other Details:
Languages:  eng     Pagination:  1619-28     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, Emory University School of Medicine, Emory University, Atlanta, GA 30322, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Apoptosis / physiology*
Cell Survival / physiology*
Cell Transplantation
Cells, Cultured
Dinoprost / genetics,  metabolism*
Female
Inhibitor of Apoptosis Proteins / genetics,  metabolism*
Mice
Mice, Inbred BALB C
Mice, Knockout
Microarray Analysis
Muscle Development / physiology
Muscle, Skeletal / cytology*,  physiology
Myoblasts / cytology,  physiology*
NFATC Transcription Factors / genetics,  metabolism
Signal Transduction / physiology
Up-Regulation
Grant Support
ID/Acronym/Agency:
AR-047314/AR/NIAMS NIH HHS; AR-051372/AR/NIAMS NIH HHS; AR-052730/AR/NIAMS NIH HHS; R01 AR052730-01A1/AR/NIAMS NIH HHS; R01 AR052730-02/AR/NIAMS NIH HHS
Chemical
Reg. No./Substance:
0/BIRC6 protein, mouse; 0/Inhibitor of Apoptosis Proteins; 0/NFATC Transcription Factors; 0/Nfatc1 protein, mouse; 551-11-1/Dinoprost
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cell death in the host response to infection.
Next Document:  Caspase-8 deficiency facilitates cellular transformation in vitro.